Iovance Biotherapeutics Inc. logo

Iovance Biotherapeutics Inc.

IOVA | NASDAQ
Chart Builder DCF Calculator
$10.19
-$0.06 (-0.59%)
At close: Sep 21, 2026, 4:00 PM ET
$10.22
+$0.03 (+0.27%)
Pre-market: Sep 22, 2026, 8:07 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
163.08M 115.69M 114.89M 231.73M 78.23M 67.33M
Short-Term Investments
133.9M 208.09M 164.98M 240.11M 426.18M 562.11M
Long-Term Investments
n/a n/a 66.43M n/a 91.59M n/a
Other Long-Term Assets
14.15M 6.73M 270K 6.62M 7.87M 18.44M
Receivables
82.45M 69.34M 151K n/a n/a n/a
Inventory
51.68M 51.52M 10.37M n/a n/a n/a
Other Current Assets
11.58M 12.38M 17.46M 7.27M n/a n/a
Total Current Assets
442.69M 457.02M 307.85M 479.12M 507.96M 636.1M
Property-Plant & Equipment
177.01M 164.28M 176.55M 178.25M 169.92M 113.92M
Goodwill & Intangibles
279.32M 282.4M 229.26M n/a n/a n/a
Total Long-Term Assets
470.48M 453.41M 472.5M 184.87M 269.38M 132.36M
Total Assets
913.17M 910.43M 780.35M 663.98M 777.33M 768.46M
Account Payables
22.16M 27.51M 33.12M 26.6M 27.38M 13.51M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
4.04M n/a n/a n/a n/a n/a
Other Current Liabilities
112.16M 50.03M 34.59M n/a n/a n/a
Total Current Liabilities
138.36M 122.34M 110.31M 91.49M 89.2M 54.87M
Long-Term Debt
n/a 1M 1M 1M 1M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 11.71M
Total Long-Term Liabilities
76.23M 77.68M 85.43M 72.86M 66.47M 57.09M
Total Liabilities
214.59M 200.02M 195.74M 164.34M 155.67M 111.96M
Total Debt
48.44M 58.26M 75.86M 85.45M 71.53M 51.66M
Book Value
698.58M 710.41M 584.61M 499.64M 621.66M 656.5M
Book Value Per Share
1.95 2.45 2.49 3.14 4.05 4.75
Common Stock
17K 13K 11K 8K 7K 6K
Retained Earnings
-2.78B -2.38B -2.01B -1.57B -1.17B -830.19M
Comprehensive Income
16.44M -1.05M 2.53M -902K -601K 19K
Shareholders Equity
698.58M 710.41M 584.61M 499.64M 621.66M 656.5M
Total Investments
133.9M 208.09M 231.41M 240.11M 517.77M 562.11M

© 2026 bestshares.com. All rights reserved.